Vimarsana
Biggest News Aggregation in the World

Page 5 - Import Alert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Import Alert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Import Alert Today - Breaking & Trending Today

Enoki Mushroom Listeria Outbreak is over but still a Danger - Vimarsana News

Enoki Mushroom Listeria Outbreak is over but still a Danger

Federal officials say an outbreak of Listeria infections traced to enoki mushrooms has ended.  The Centers for Disease Control and Prevention reports

Old FDA import alert falsely shared as new US ban on Japanese food products - Vimarsana News

Old FDA import alert falsely shared as new US ban on Japanese food products

A Chinese-language newspaper report that falsely claims the US Food and Drug Administration (FDA) banned imports of Japanese food in March 2023 over "nuclear contamination" concerns has circulated on social media. However, a Japanese official from the agricultural ministry told AFP on March 31 that the ministry was ...

Source: afp.com
Virginia, West Virginia open markets to kratom - Vimarsana News

Virginia, West Virginia open markets to kratom

Bills ensuring market access to kratom recently having been signed into law in Virginia and West Virginia.

US refuses imports from Ecuadorian, Indian shrimp companies due to nitrofurans - Vimarsana News

US refuses imports from Ecuadorian, Indian shrimp companies due to nitrofurans

US FDA reufses major shrimp imports, first time since 2009

Sun Pharma Gets USFDA Warning Letter For Halol Facility Regulator Warns Action - Vimarsana News

Sun Pharma Gets USFDA Warning Letter For Halol Facility Regulator Warns Action

News and Updates for Healthcare in India - , Regulatory-The top US regulator inspected Sun Pharma's Halol facility between April 26 to May 09 in 2022 and found adulterations in drugs. The samples collected for inspection of the drug offered for import in the US and mentioned as (b)(4) capsules in the warning letter failed to meet the specification for dissolution implying that the drug is adulterated, the USFDA said